Similarly, ZBP-89 inhibition caused the downregulation of TPH1 in 5-HT–treated cells (Figure 4C), indicating that β-catenin and ZBP-89 cooperated to mediate the upregulation of TPH1, thus forming a positive feedback loop to drive prostate cancer development. Here, ZNF148 is linked to prostate carcinoma.